Aurora Spine’s Patent Related to DEXA Technology™ Patient-Matched Implant Technology Issued by the United States Patent O...
October 05 2020 - 7:48PM
Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:
ASG), a designer and manufacturer of innovative medical devices
that improve spinal surgery outcomes, today announced the issuance
of its United States Patent No: 10,779,954 entitled “Body Density
Scan Result-Matched Orthopedic Implants and Methods of Use” for The
World’s First DEXA Technology™ Patient-Matched Implant Technology.
Aurora Spine’s first-of-its kind DEXA Technology™ is designed to
match a patient’s bone density, promote bone in-growth while
maintaining the biomechanical structure and bone support. This
patent will be utilized to create implants that match the patient’s
specific bone density based on a DEXA Scan/T-score allowing for the
best bone fusion treatment and most favorable outcome based on that
patient’s bone density.
Aurora Spine’s DEXA Technology™ is part of the company's
advanced portfolio representing the future of Spinal and Orthopedic
implants. Following fundamental principles of patent focused
innovation, DEXA Technology™ was logically created and patented to
combine the essential design benefits of conventional machining, 3D
printing, and additive implant manufacturing.
"Aurora Spine’s new DEXA Technology™ will provide surgeons with
additional solutions in selecting the right implant for their
patient," said Trent Northcutt, CEO of Aurora Spine. "The DEXA
opportunity represents our continued commitment to delivering
best-in-class implants that enable our surgeon partners to overcome
common osteoporosis challenges faced in traditional procedures. We
will be commercializing this technology in the coming months.”
Laszlo Garamszegi, Chief Technology Officer of Aurora Spine,
added “Traditionally, medical devices for spinal procedures are
designed as ‘one size fits all’ and assumes that every patient’s
bone density is similar. The proprietary engineering behind our
DEXA Technology™ is advancing the science of implant technology,
and ultimately helping improve patient fusion rates and overall
clinical outcomes.”
About Aurora Spine
Aurora Spine is focused on bringing new solutions to the spinal
implant market through a series of innovative, minimally invasive,
regenerative spinal implant technologies.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking Information" in
Aurora Spine's final prospectus (collectively, "forward-looking
information"). Forward-looking information in this news release
includes information concerning the proposed use and success of the
company’s products in surgical procedures. Aurora Spine cautions
investors of Aurora Spine's securities about important factors that
could cause Aurora Spine's actual results to differ materially from
those projected in any forward-looking statements included in this
news release. Any statements that express, or involve discussions
as to, expectations, beliefs, plans, objectives, assumptions or
future events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward-looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Contact:
Aurora Spine Corporation
Trent NorthcuttPresident and Chief Executive Officer(760)
424-2004
Chad ClouseChief Financial Officer(760)
424-2004www.aurora-spine.com
Adam Lowensteiner LYTHAM PARTNERS, LLCPhoenix | New
YorkTelephone: 646-829-9700arosf@lythampartners.com
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aurora Spine (TSXV:ASG)
Historical Stock Chart
From Apr 2023 to Apr 2024